![Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/75/1/159/F2.large.jpg)
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews
![Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology](https://www.jmcc-online.com/cms/attachment/40342408-2f7e-4c60-acc2-1240f8d20b68/ga1_lrg.jpg)
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology
![Remodeling With Neointima Formation in the Mouse Carotid Artery After Cessation of Blood Flow | Arteriosclerosis, Thrombosis, and Vascular Biology Remodeling With Neointima Formation in the Mouse Carotid Artery After Cessation of Blood Flow | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/fb1f1155-e1ad-4902-8003-68b5318e995c/hq1070262001.jpeg)
Remodeling With Neointima Formation in the Mouse Carotid Artery After Cessation of Blood Flow | Arteriosclerosis, Thrombosis, and Vascular Biology
![Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality | Circulation Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality | Circulation](https://www.ahajournals.org/cms/asset/79242312-580c-4348-baa5-ab92f27ee485/12ff2.jpg)
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality | Circulation
![Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/75/1/159/F3.large.jpg)
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews
![High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor | Circulation High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor | Circulation](https://www.ahajournals.org/cms/asset/6a34fbeb-1da7-460a-9108-30881169e0ae/12ff4.jpeg)
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor | Circulation
![Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning | Pharmacological Reviews](https://pharmrev.aspetjournals.org/sites/default/files/highwire/pharmrev/75/1.cover-source.jpg)